Mobikwik shares list at 59% premium; How Vishal Mega Mart & Sai Life fared on debut?
One Mobikwik Systems, Vishal Mega and Sai Lfie Sciences delivered 20-60 per cent listing pop to the investors on debut.
- Dec 18, 2024,
- Updated Dec 18, 2024 10:49 AM IST
Shares of One Mobikwik Systems, Vishal Mega Mart and Sai Life Sciences made their Dalal Street debut on Wednesday. All three issues were open for bidding between December 11-13, cumulatively raising Rs 11,615 crore via primary market. These issues had received a strong response from the investors.
Shares of Sai Life Sciences were listed with a premium of 20.22 per cent at Rs 660 on BSE over the issue price of Rs 522. Similarly, the pharmaceuticals kicked off its maiden trading session at Rs 650 on NSE, with a premium of 18.40 per cent over the given issue price.
The listing of Sai Life Sciences has been on the expected lines. Ahead of its debut, shares of Sai Life Sciences were commanding a grey market premium of 70-72 apiece suggesting a listing pop of close to 13 per cent for the investors. The GMP for the counter stood at Rs 60-62 a day earlier.
The IPO of Sai Life Sciences offered its shares in the price band of Rs 522-549 per share with a lot size of 27 shares. The Hyderabad-based company raised a total of Rs 3,042.62 crore via IPO, which was included a fresh share sale of Rs 950 crore and offer-for-sale (OFS) of up to 3,81,16,934 equity shares. The issue was overall subscribed a 10.26 times.
Shares of One Mobikwik Systems, Vishal Mega Mart and Sai Life Sciences made their Dalal Street debut on Wednesday. All three issues were open for bidding between December 11-13, cumulatively raising Rs 11,615 crore via primary market. These issues had received a strong response from the investors.
Shares of Sai Life Sciences were listed with a premium of 20.22 per cent at Rs 660 on BSE over the issue price of Rs 522. Similarly, the pharmaceuticals kicked off its maiden trading session at Rs 650 on NSE, with a premium of 18.40 per cent over the given issue price.
The listing of Sai Life Sciences has been on the expected lines. Ahead of its debut, shares of Sai Life Sciences were commanding a grey market premium of 70-72 apiece suggesting a listing pop of close to 13 per cent for the investors. The GMP for the counter stood at Rs 60-62 a day earlier.
The IPO of Sai Life Sciences offered its shares in the price band of Rs 522-549 per share with a lot size of 27 shares. The Hyderabad-based company raised a total of Rs 3,042.62 crore via IPO, which was included a fresh share sale of Rs 950 crore and offer-for-sale (OFS) of up to 3,81,16,934 equity shares. The issue was overall subscribed a 10.26 times.